Molecule Information
General Information of the Molecule (ID: Mol00583)
| Name |
Ras-related protein Rab-14 (RAB14)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Molecule Type |
Protein
|
||||
| Gene Name |
RAB14
|
||||
| Gene ID | |||||
| Location |
chr9:121178133-121223014[-]
|
||||
| Sequence |
MATAPYNYSYIFKYIIIGDMGVGKSCLLHQFTEKKFMADCPHTIGVEFGTRIIEVSGQKI
KLQIWDTAGQERFRAVTRSYYRGAAGALMVYDITRRSTYNHLSSWLTDARNLTNPNTVII LIGNKADLEAQRDVTYEEAKQFAEENGLLFLEASAKTGENVEDAFLEAAKKIYQNIQDGS LDLNAAESGVQHKPSAPQGGRLTSEPQPQREGCGC Click to Show/Hide
|
||||
| Function |
Involved in membrane trafficking between the Golgi complex and endosomes during early embryonic development. Regulates the Golgi to endosome transport of FGFR-containing vesicles during early development, a key process for developing basement membrane and epiblast and primitive endoderm lineages during early postimplantation development. May act by modulating the kinesin KIF16B-cargo association to endosomes (By similarity). Regulates, together with its guanine nucleotide exchange factor DENND6A, the specific endocytic transport of ADAM10, N-cadherin/CDH2 shedding and cell-cell adhesion.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Kidney cancer | [1] | |||
| Sensitive Disease | Kidney cancer [ICD-11: 2C90.1] | |||
| Sensitive Drug | Cisplatin | |||
| Molecule Alteration | Expression | Down-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | Caspase signaling pathway | Activation | hsa04210 | |
| In Vitro Model | Caki cells | Kidney | Homo sapiens (Human) | CVCL_0234 |
| Experiment for Molecule Alteration |
RT-PCR; Western blot analysis | |||
| Experiment for Drug Resistance |
Flow cytometry assay; PI/Annexin staining assay | |||
| Mechanism Description | miR148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells, transfection with the miR148a mimics resulted in the activation of caspase pathway. | |||
Disease- and Tissue-specific Abundances of This Molecule
ICD Disease Classification 02
| Differential expression of molecule in resistant diseases | ||
| The Studied Tissue | Kidney | |
| The Specified Disease | Kidney cancer | |
| The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.38E-01; Fold-change: 2.13E-01; Z-score: 3.40E-01 | |
| The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 7.31E-01; Fold-change: 1.66E-01; Z-score: 4.36E-01 | |
|
Molecule expression in the normal tissue adjacent to the diseased tissue of patients
Molecule expression in the diseased tissue of patients
Molecule expression in the normal tissue of healthy individuals
|
||
| Disease-specific Molecule Abundances |
|
Click to View the Clearer Original Diagram |
Tissue-specific Molecule Abundances in Healthy Individuals
|
||
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
